Delivery Order SPE2DB20D3101-SPE2DB25FRSH2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,432.43 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Veozah 45 mg tablets (30-count package) valued at $1,532.04. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by August 20, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,038.28 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a small-value pharmaceutical transaction under a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for Veozah 45 mg tablets (30 count) with a ceiling value of $1,518.30 under a firm fixed-price contract. The award was competitively procured with no set-aside designation and has an ultimate completion date of August 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Veozah 45 mg tablets (30-count units) under a firm fixed-price contract valued at $13,060.20. This delivery order, which is not set-aside for any socioeconomic category, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 billion through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,921.89 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Veozah 45 mg tablets (30-count packaging). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. The pharmaceutical product will be performed at the contractor's Conshohocken facility, with an ultimate completion date of August 1, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,872.10 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30 count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $17,319.74. This firm fixed-price delivery order, awarded on July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and will be performed at the contractor's...
- This delivery order, awarded July 31, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 30 tablets of Veozah 45 mg with a ceiling value of $1,846.62 and completion date of August 1, 2025. The order represents a competitively awarded, firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on July 24, 2025, carries a ceiling value of approximately $21.1K and is set to reach ultimate completion by July 25, 2025. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSH2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,292.12 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen Drug Corp's extensive pharmaceutical supply portfolio with the Defense Logistics Agency. The award leverages the company's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the overarching vehicle for global pharmaceutical support to military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a comprehensive contract portfolio with the federal government covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency and military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/11/25 |